Craft

RTsafe

Revenue

€495 K

FY, 2022

RTsafe Summary

Company Summary

Overview
RTsafe Holding is a medical technology company specializing in 3D-printed dosimetry phantoms. It offers a PseudoPatient personalized care solution for brain tumor patients, a phantom Prime that enables 3D gel dosimetry measurements, a single-use head phantom Encephalon 3D, and an anthropomorphic 3D-printed SBRT and Spine phantoms. The company also provides remote dosimetry and preparation for ISRS certification services.
Type
Private
Status
Active
Founded
2014
HQ
Athens, GR | view all locations
Website
https://rt-safe.com/
Cybersecurity rating
Sectors

Key People

  • Evangelos Pappas

    Evangelos Pappas, Founder & Chief Scientific Officer

    • Thomas Maris

      Thomas Maris, Co-Founder & Head of MRI QA Lab

      • Fanis Filis

        Fanis Filis, Chief Financial Officer

        LocationsView all

        3 locations detected

        • Athens HQ

          Greece

          Artotinis 48

        • Dublin, D

          Ireland

          Regus-Alexandra House Ballsbridge Business Park Ballsbridge Park, Merrion Road

        • London, England

          United Kingdom

          King’s College, London Strand

        RTsafe Financials

        Summary Financials

        Revenue (FY, 2022)
        €495.0K
        Gross profit (FY, 2022)
        €463.7K
        Net income (FY, 2022)
        €528.5K

        Footer menu